Article(id=1330225793575268945, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225632362999820, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.06.015, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1642348800000, receivedDateStr=2022-01-17, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080143587, onlineDateStr=2026-11-19, pubDate=1654790400000, pubDateStr=2022-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080143587, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080143587, creator=13701087609, updateTime=1795080143587, updator=13701087609, issue=Issue{id=1330225632362999820, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='6', pageStart='643', pageEnd='810', issueExtLink='null', onlineDate='null', pubDate='1654790400000', pubDateStr='2022-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795080105152, creator='13701087609', updateTime=1795084738205, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330245065345184449, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225632362999820, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330245065345184450, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225632362999820, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=736, endPage=745, ext={EN=ArticleExt(id=1330225793852093010, articleId=1330225793575268945, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Cost-utility analysis of osimertinib for adjuvant treatment of epidermal grouth factor receptor mutation-positive non-small cell lung cancer, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective To evaluate the cost-effectiveness of osimertinib for adjuvant treatment of patients with epidermal grouth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) after tumor resection from the perspective of Chinese healthcare system.
Methods A 5-state Markov model with 1-month cycle was constructed, and the lifetime horizon was used. Data on patient baseline characteristics, transition probabilities, incidence of adverse events and health utilities were mainly derived from ADAURA study, supplemented by CancerLinQ database, FLAURA study and published literatures. Medical costs were derived from Chinese government documents, literature, and clinical expert surveys. Scenario analysis, one-way sensitivity analysis and probabilistic sensitivity analysis were conducted simultaneously.
Results Base-case analysis results showed that for patients with EGFR mutation-positive NSCLC after tumor resection, the incremental cost of osimertinib compared with placebo was 25 395.25 yuan, the incremental quality adjusted life year (QALY) was 3.25, the incremental cost-effectiveness ratio (ICER) was 7 812.45 yuan/QALY, which was much lower than 1 times Chinese per capita GDP (72 447.00 yuan in 2020). Osimertinib has cost-effectiveness. Scenario analysis, one-way sensitivity analysis and probabilistic sensitivity analysis indicated that base-case analysis results were robust.
Conclusion Under the threshold of 1-time Chinese per capita GDP, osimertinib was predicted to be the cost-effective treatment option compared with placebo for patients with EGFR mutation-positive NSCLC after tumor resection in China.
, authors=Jia LIU
1, 2, Xiaoning HE
1, 2, *, authorsList=Jia LIU, Xiaoning HE, authorCompany=null, correspAuthors=Xiaoning HE, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225794233774675, articleId=1330225793575268945, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=奥希替尼用于表皮生长因子受体突变阳性非小细胞肺癌辅助治疗的成本-效用分析, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的 从中国医疗卫生体系角度出发,评价奥希替尼用于表皮生长因子(epidermal grouth factor receptor,EGFR)突变阳性非小细胞肺癌(non-small cell lung cancer,NSCLC)肿瘤切除术后辅助治疗的成本-效果。
方法 构建五状态Markov模型,模型循环周期为1个月,模拟时限为患者终身。患者基线特征、状态间转移概率、不良事件发生率及健康效用数据主要来源于ADAURA研究,同时以CancerLinQ数据库、FLAURA研究及其他既往文献数据作为补充。医疗成本数据来源于官方发布的药品/医疗服务项目价格文件、文献及临床专家调研。同时,开展情境、单因素敏感性和概率敏感性分析。
结果 基础分析结果显示,对于EGFR突变阳性NSCLC肿瘤切除术后辅助治疗的患者,奥希替尼相比安慰剂的增量成本为25 395.25元,增量质量调整生命年(quality-adjusted life year,QALY)为3.25,增量成本-效果比(incremental cost-effectiveness ratio,ICER)为7 812.45元/QALY,远低于1倍中国人均GDP(2020年为72 447.00元),奥希替尼具有成本-效果。情境、单因素和概率敏感性分析显示,基础分析结果稳健。
结论 在1倍人均GDP的阈值下,奥希替尼相比安慰剂,用于中国EGFR突变阳性NSCLC患者肿瘤切除术后辅助治疗具有成本-效果。
, authors=刘佳
1, 2, 贺小宁
1, 2, *, authorsList=刘佳, 贺小宁, authorCompany=null, correspAuthors=贺小宁, authorNote=
刘佳,博士研究生,研究方向:决策分析模型构建与药物经济学。
, correspAuthorsNote=
贺小宁,副教授,研究方向:卫生经济学与药物经济学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=8/cvhEkDRb3+kkzOlsK6wA==, magXml=6Fb6coW/smeWP0bR6hrQ/Q==, pdfUrl=null, pdf=KgCieoNlmKRV48Q+fMweLg==, pdfFileSize=1867487, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=7CSUYzW5YJKkKQi1qbfPQA==, mapNumber=null, fund=null)}, authors=[Author(id=1330225794678370907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225794753868382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, authorId=1330225794678370907, language=EN, stringName=Jia LIU, firstName=Jia, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China
2.Center for Social Science Survey and Data, Tianjin University, Tianjin 300072, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225794829365855, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, authorId=1330225794678370907, language=CN, stringName=刘佳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, address=
1.天津大学药物科学与技术学院,天津 300072
2.天津大学社会科学调查与数据中心,天津 300072, bio={"content":"
刘佳,博士研究生,研究方向:决策分析模型构建与药物经济学。
"}, bioImg=null, bioContent=
刘佳,博士研究生,研究方向:决策分析模型构建与药物经济学。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225794481238612, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, xref=1., ext=[AuthorCompanyExt(id=1330225794493821525, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794481238612, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China), AuthorCompanyExt(id=1330225794502210134, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794481238612, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.天津大学药物科学与技术学院,天津 300072)]), AuthorCompany(id=1330225794581901911, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, xref=2., ext=[AuthorCompanyExt(id=1330225794590290520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794581901911, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Center for Social Science Survey and Data, Tianjin University, Tianjin 300072, China), AuthorCompanyExt(id=1330225794598679129, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794581901911, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.天津大学社会科学调查与数据中心,天津 300072)])]), Author(id=1330225794925834849, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225795055858276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, authorId=1330225794925834849, language=EN, stringName=Xiaoning HE, firstName=Xiaoning, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, *, address=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China
2.Center for Social Science Survey and Data, Tianjin University, Tianjin 300072, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225795135550053, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, authorId=1330225794925834849, language=CN, stringName=贺小宁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, 2, *, address=
1.天津大学药物科学与技术学院,天津 300072
2.天津大学社会科学调查与数据中心,天津 300072, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225794481238612, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, xref=1., ext=[AuthorCompanyExt(id=1330225794493821525, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794481238612, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China), AuthorCompanyExt(id=1330225794502210134, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794481238612, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.天津大学药物科学与技术学院,天津 300072)]), AuthorCompany(id=1330225794581901911, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, xref=2., ext=[AuthorCompanyExt(id=1330225794590290520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794581901911, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Center for Social Science Survey and Data, Tianjin University, Tianjin 300072, China), AuthorCompanyExt(id=1330225794598679129, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794581901911, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.天津大学社会科学调查与数据中心,天津 300072)])])], keywords=[Keyword(id=1330225795227824742, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=EN, orderNo=1, keyword=osimertinib), Keyword(id=1330225795307516519, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=EN, orderNo=2, keyword=non-small cell lung cancer), Keyword(id=1330225795378819688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=EN, orderNo=3, keyword=adjuvant treatment), Keyword(id=1330225795475288681, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=EN, orderNo=4, keyword=cost-utility analysis), Keyword(id=1330225795601117802, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=EN, orderNo=5, keyword=Markov model), Keyword(id=1330225795659838059, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=CN, orderNo=1, keyword=奥希替尼), Keyword(id=1330225797350142573, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=CN, orderNo=2, keyword=非小细胞肺癌), Keyword(id=1330225797421445742, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=CN, orderNo=3, keyword=辅助治疗), Keyword(id=1330225797501137519, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=CN, orderNo=4, keyword=成本-效用分析), Keyword(id=1330225797572440688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, language=CN, orderNo=5, keyword=Markov模型)], refs=[Reference(id=1330225797656326769, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=International Agency for Research on Cance. GLOBOCAN 2020[EB/OL]. [2022-01-17]. http://globocan.iarc.fr/., articleTitle=null, refAbstract=null), Reference(id=1330225797723435635, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Siegel R, Ma J, Zou Z,
et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1): 9-29., articleTitle=null, refAbstract=null), Reference(id=1330225797828293236, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Datta D, Lahiri B. Preoperative evaluation of patients undergoing lung resection surgery[J]. Chest, 2003, 123(6): 2096-2103., articleTitle=null, refAbstract=null), Reference(id=1330225797916373621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Chansky K, Detterbeck FC, Nicholson AG,
et al. The IASLC Lung Cancer Staging Project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer[J]. J Thorac Oncol, 2017, 12(7): 1109-1121., articleTitle=null, refAbstract=null), Reference(id=1330225798000259702, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Pignon JP, Tribodet H, Scagliotti GV,
et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group[J]. J Clin Oncol, 2008, 26(21): 3552-3559., articleTitle=null, refAbstract=null), Reference(id=1330225798058979959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=NSCLC Meta-analyses Collaborative Group, Arriagada R, Auperin A,
et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data[J]. Lancet, 2010, 375(9722): 1267-1277., articleTitle=null, refAbstract=null), Reference(id=1330225798147060344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Kelly K, Altorki NK, Eberhardt WE,
et al. Adjuvant erlotinib versus placebo in patients with stage ⅠB-ⅢA non-small cell lung cancer (RADIANT): a randomized, double-blind, phase Ⅲ trial[J]. J Clin Oncol, 2015, 33(34): 4007-4014., articleTitle=null, refAbstract=null), Reference(id=1330225798235140729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhong WZ, Wang Q, Mao WM,
et al. Gefitinib
versus vinorelbine plus cisplatin as adjuvant treatment for stageⅡ~ⅢA(N1-N2)
EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study[J]. Lancet Oncol, 2018;19(1): 139-148., articleTitle=null, refAbstract=null), Reference(id=1330225798310638202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Yue D, Xu S, Wang Q,
et al. Erlotinib
versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage ⅢA
EGFR mutation positive non-small cell lung cancer (EVAN): a randomised, open-label, phase 2 trial[J]. Lancet Respir Med, 2018, 6(11): 863-873., articleTitle=null, refAbstract=null), Reference(id=1330225798394524283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu YL, Tsuboi M, He J,
et al. Osimertinib in resected
EGFR-mutated non-small-cell lung cancer[J]. N Engl J Med, 2020, 383(18): 1711-1723., articleTitle=null, refAbstract=null), Reference(id=1330225798524547708, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology Non-small Cell Lung Cancer version 5, 2021[EB/OL]. [2022-01-17]. http://www.nccn.org/patients., articleTitle=null, refAbstract=null), Reference(id=1330225798621016701, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Remon J, Soria JC, Peters S. Early and locally advanced non-small-cell lung cancer: an update of the ESMO clinical practice guidelines focusing on diagnosis, staging, systemic and local therapy[J]. Ann Oncol, 2021, 32(12): 1637-1642., articleTitle=null, refAbstract=null), Reference(id=1330225798683931263, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会肿瘤学分会肺癌临床诊疗指南(2021版)[J]. 中华医学杂志, 2021, 101(23): 1725-1757., articleTitle=null, refAbstract=null), Reference(id=1330225798759428736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)非小细胞肺癌诊疗指南(2020版)[M]. 北京: 人民卫生出版社, 2020., articleTitle=null, refAbstract=null), Reference(id=1330225798855897729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=中国抗癌协会肺癌专业委员会, 中华医学会肿瘤学分会肺癌学组, 中国胸部肿瘤研究协作组. Ⅰ~ⅢB期非小细胞肺癌完全切除术后辅助治疗指南(2021版)[J]. 中华医学杂志. 2021, 101(16): 1132-1142., articleTitle=null, refAbstract=null), Reference(id=1330225798939783810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=刘国恩, 胡善联, 吴久鸿, 等. 中国药物经济学评价指南2020[M]. 北京: 中国市场出版社, 2020., articleTitle=null, refAbstract=null), Reference(id=1330225799015281283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=中国国家统计局人口与就业统计司. 中国人口和就业统计年鉴—2019[M]. 北京: 中国统计出版社, 2019., articleTitle=null, refAbstract=null), Reference(id=1330225799086584452, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Rubinstein SM, Warner JL. Cancer LinQ: origins, implementatioon, and future directions[J]. JCO Clin Cancer Inform, 2018, 2: 1-7., articleTitle=null, refAbstract=null), Reference(id=1330225799149499013, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Soria JC, Ohe Y, Vansteenkiste J,
et al. Osimertinib in untreated EGFR mutated advanced non-small-cell lung cancer[J]. N Engl J Med, 2018, 378(2): 113-125., articleTitle=null, refAbstract=null), Reference(id=1330225799224996486, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=中华人民共和国国家卫生健康委员会. 中国居民营养与慢性病状况报告(2020年)[EB/OL]. (2020-12-23) [2022-01-17]. https://baijiahao.baidu.com/s?id=1688190172630192257&wfr=spider&for=pc., articleTitle=null, refAbstract=null), Reference(id=1330225799308882567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=刘心怡, 陈文. 奥希替尼用于
EGFR+晚期非小细胞肺癌患者一线治疗的药物经济学评价[J]. 世界临床药物, 2021, 42(2): 135-142., articleTitle=null, refAbstract=null), Reference(id=1330225799375991432, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=张力, 周彩存, 赵军, 等. 阿来替尼一线治疗中国ALK阳性晚期或转移性非小细胞肺癌的成本效果研究[J]. 中国医疗保险, 2019, (12): 56-62., articleTitle=null, refAbstract=null), Reference(id=1330225799455683209, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Wu B, Gu XH, Zhang Q. Cost-effectiveness of osimertinib for
EGFR mutation: positive non-small cell lung cancer after progression following first-line
EGFR TKI therapy[J]. J Thorac Oncol, 2018, 13(2): 184-193., articleTitle=null, refAbstract=null), Reference(id=1330225799539569290, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Guan HJ, Liu G, Xie F,
et al. Cost-effectiveness of osimertinib as a second-line treatment in patients with
EGFR-mutated advanced nonesmall cell lung cancer in China[J]. Clin Ther, 2019, 41(11): 2308-2320, articleTitle=null, refAbstract=null), Reference(id=1330225799619261067, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Nafees B, Lloyd AJ, Dewilde S,
et al. Health state utilities in non- small cell lung cancer: an international study[J]. Asia Pac J Clin Oncol, 2017, 13(5): e195-e203., articleTitle=null, refAbstract=null), Reference(id=1330225799686369932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Nafees B, Stafford M, Gavriel S,
et al. Health state utilities for non-small cell lung cancer[J]. Health Qual Life Outcomes, 2008, 6: 84., articleTitle=null, refAbstract=null), Reference(id=1330225799749284493, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Lloyd A, Nafees B, Narewska J,
et al. Health state utilities for metastatic breast cancer[J]. Br J Cancer, 2006, 95(6): 683-690., articleTitle=null, refAbstract=null), Reference(id=1330225799808004750, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation[M]. Oxford: Oxford University Pres, 2006., articleTitle=null, refAbstract=null), Reference(id=1330225799875113615, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Aguiar PN Jr, Haaland B, Park W,
et al. Cost-effectiveness of osimertinib in the first-line treatment of patients with
EGFR-mutated advanced non-small cell lung cancer[J]. JAMA Oncology, 2018, 4(8): 1080-1084., articleTitle=null, refAbstract=null), Reference(id=1330225800030302864, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Aziz MIA, Foo WYX, Toh CK,
et al. Cost-effectiveness analysis of osimertinib for first-line treatment of locally advanced or metastatic
EGFR mutation positive non-small cell lung cancer in Singapore[J]. J Med Econ, 2020, 23(11): 1330-1339., articleTitle=null, refAbstract=null), Reference(id=1330225800097411729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Khoo T, Gao L. Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for locally advanced or metastatic
EGFR mutation-positive non-small cell lung cancer in Australia[J]. Expert Rev Pharmacoecon Outcomes Res, 2021, 21(3): 415-423., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225794481238612, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, xref=1., ext=[AuthorCompanyExt(id=1330225794493821525, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794481238612, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China), AuthorCompanyExt(id=1330225794502210134, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794481238612, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.天津大学药物科学与技术学院,天津 300072)]), AuthorCompany(id=1330225794581901911, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, xref=2., ext=[AuthorCompanyExt(id=1330225794590290520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794581901911, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Center for Social Science Survey and Data, Tianjin University, Tianjin 300072, China), AuthorCompanyExt(id=1330225794598679129, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225793575268945, companyId=1330225794581901911, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.天津大学社会科学调查与数据中心,天津 300072)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.06.015, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.06.015, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.06.015, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.06.015, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1654790400000, fullTextJson=null, articleText=null, reference=null)